Scott Lauder

Title: Scott Lauder: Innovator in Antibody Development

Introduction

Scott Lauder is a prominent inventor based in Somerville, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target complement activation. His innovative work has the potential to impact various medical treatments.

Latest Patents

Scott Lauder holds a patent for "Factor H potentiating antibodies and uses thereof." This patent includes novel isolated, synthetic, or recombinant antibodies and fragments that are specific for factor H. Additionally, it covers the use of these antibodies, fragments, nucleic acids, or vectors for inhibiting complement activation and treating disorders associated with complement activation. He has 1 patent to his name.

Career Highlights

Throughout his career, Scott has worked with notable companies in the biotechnology sector. He has been associated with Gemini Therapeutics Sub, Inc. and Stichting Sanquin Bloedvoorziening. His work in these organizations has furthered the understanding and application of antibody therapies.

Collaborations

Scott has collaborated with esteemed colleagues, including Tom Purcell and Sridhar Govindarajan. These partnerships have contributed to the advancement of research in the field of complement activation and antibody development.

Conclusion

Scott Lauder's innovative work in antibody development showcases his commitment to advancing medical science. His contributions have the potential to lead to significant breakthroughs in the treatment of disorders related to complement activation.